8-KOther Events

HCA Healthcare, Inc. 8-K Report, Corporate Update (May 11, 2016)

Filed May 11, 2016For Securities:HCA

Summary

HCA Holdings, Inc. (HCA) announced on May 10, 2016, that it entered into a Share Repurchase Agreement to buy back approximately 9.36 million shares of its common stock from affiliates of Kohlberg Kravis Roberts & Co. (KKR). This significant share repurchase is being executed at a price of $80.12 per share, which represents the closing price on May 10, 2016, less a 1% discount. The transaction is a notable use of HCA's existing $3.0 billion share repurchase program, authorized in October 2015. Following this repurchase, the company will have utilized $2.09 billion of the authorized program. This action signals management's confidence in the company's valuation and its commitment to returning capital to shareholders, potentially boosting earnings per share by reducing the outstanding share count.

Key Highlights

  • 1HCA Holdings, Inc. to repurchase 9,360,958 shares of common stock from KKR affiliates.
  • 2The repurchase price is $80.12 per share, based on the May 10, 2016 closing price less a 1% discount.
  • 3This transaction is part of HCA's existing $3.0 billion share repurchase program approved in October 2015.
  • 4Following this repurchase, $2.09 billion of the program will have been utilized.
  • 5The repurchase involves shares beneficially owned by affiliates of Kohlberg Kravis Roberts & Co. (KKR).
  • 6The event date of the agreement was May 10, 2016.

Frequently Asked Questions

This 8-K filing announces HCA Holdings, Inc.'s entry into a Share Repurchase Agreement to buy back a significant number of its own shares from an affiliate of Kohlberg Kravis Roberts & Co. (KKR).

HCA is repurchasing 9,360,958 shares at $80.12 per share. The total value of this specific transaction is approximately $750 million (9,360,958 shares * $80.12/share).

Yes, this repurchase is funded by HCA's existing $3.0 billion share repurchase program. It represents a significant deployment of capital under that program, indicating management's commitment to returning value to shareholders.

This transaction represents a substantial divestment by KKR from their holdings in HCA and a key use of HCA's share buyback authorization. It reduces the number of outstanding shares, which can increase earnings per share and signal management's belief that the stock is undervalued.